Free Blood Test for Cats: Take Precaution Now!

Many cats suffer from undetected diseases. Boehringer Ingelheim now offers free blood tests for cats nationwide – redeemable with a voucher until August 15, 2025.

Risks of Automatic Substitution of Biopharmaceuticals

Automatic substitution of biopharmaceuticals poses major risks to patient care and Germany’s pharmaceutical sector, leading industry associations warn.

Pneumococcal Infections on the Rise – Vaccination Rates Still Low

While the flu wave has peaked, pneumococcal infections are on the rise. Older people are especially at risk – vaccination offers effective protection.

Vetter Recognized Again as Best Managed Company

Vetter has once again been recognized as a “Best Managed Company” in its anniversary year. The award honors the company's strategic focus and sustainable management approach.

Pharmacy and Science: A Glimpse into the Future

INTERPHARM 2025 in Stuttgart delivers cutting-edge insights into autoimmune diseases, skin health, eye care, and the future of healthcare. Discover the highlights now!

Health Insurers Warn: Premium Surcharges to Rise Again

Germany’s public health insurers warn of rising premium surcharges. Hospital stays, medication costs, and more severe illnesses are driving up expenses.

EU reviews producer responsibility in wastewater directive

The EU Commission is reviewing the costs and impacts of extended producer responsibility in the Urban Wastewater Directive. Pharma Germany welcomes the move.

Reimbursable Medications for Smoking Cessation Approved

Patients with severe tobacco addiction can now receive reimbursable medications like nicotine or varenicline as part of certified cessation programs.

ITM Secures Up to $262.5M in Financing from Blue Owl

ITM secures up to $262.5M from Blue Owl to support the commercialization of ITM-11 and expand its radiopharmaceutical pipeline.

Health Policy in the Spotlight: German Medical Assembly in Leipzig

The 129th German Medical Assembly is bringing healthcare policy to Leipzig – with Health Minister Nina Warken and topics like AI, fee regulation, and abortion on the agenda.